Trump’s meeting with pharma execs canceled after drug lobbies refuse to show up

” The White House has actually been more than accommodating in attempts to schedule this conference,” a White House official speaking background informed Politico.

Drug lobbies have refused to send out any agents to a White House meeting set up for July 28 in which they would go over current executive orders on drug prices with President Donald Trump, according to Politico.

During a July 28 news conference, President Trump told drugmakers they have a month to propose a much better option to the new guidelines.

BIO, a lobby that advocates for small biotech business told Politico new policies will impact its drugmakers the most, as the prices of their pricey cancer and chronic illness drugs would alter significantly.

Pharma market executives told Politico they are still processing the 4 executive orders launched on July 24, as they are worried the new guidelines will hinder innovation and drug accessibility.

“We stay prepared to discuss methods to decrease costs for patients at the drug store counter. We remain steadfastly opposed to policies that would allow foreign federal governments to set prices for medicines in the United States.”.

Katie Adams –
Tuesday, July 28th, 2020
Print|Email.

More short articles on drug store: Walgreens CEO steps downAstraZeneca, Daiichi Sankyo partner in $6B cancer drug dealAstraZeneca to pay Emergent $174M to broaden production of COVID-19 vaccine prospect.

“We remain ready to go over methods to lower costs for clients at the drug store counter. We stay steadfastly opposed to policies that would permit foreign federal governments to set rates for medicines in the United States.”.

© Copyright ASC COMMUNICATIONS 2020.

© Copyright ASC COMMUNICATIONS 2020. Intrigued in LINKING to or REPRINTING this material? View our policies by click on this link.